Abstract: A neutral beam-assisted atomic layer chemical vapor deposition (ALCVD) apparatus is provided for uniformly depositing an oxide layer filling a planarization layer or a trench to increase uniformity and density of the oxide layer using neutral beams generated by a neutral beam generator without a seam or void occurring in an atomic layer deposition (ALD) or ALD-like chemical vapor deposition (CVD) process, thereby solving problems on the void or seam and low density occurring when a high-density planarization layer or a shallow trench having a width of 65 nm or less is formed, and improving a next generation oxide layer isolation process.

Abstract: This invention relates to methods of diagnosing dilated cardiomyopathy using analysis of the lamin A protein and sumylation of same, as well as methods for treating dilated cardiomyopathy, comprising enhancing the sumoylation of the lamin A protein in a subject in need thereof.

Abstract: Nucleic acids containing unmethylated CpG dinucleotides and therapeutic utilities based on their ability to stimulate an immune response and to redirect a Th2 response to a Th1 response in a subject are disclosed. Methods for treating atopic diseases, including atopic dermatitis, are disclosed.

Abstract: Examples of the present invention include antennas and scattering elements having a metamaterial cloak configured so as to reduce effects on the operating parameters of a nearby antenna. For example, an antenna has an antenna frequency, and a cloak is disposed around the antenna having a frequency range in which the cloak is operative. The antenna frequency can lie outside the frequency range of the cloak, whereas the frequency of a second antenna lies within the frequency range of the cloak. In this case, the antenna is cloaked relative to the second antenna.

Abstract: Isolation and purification of stem cells from within a bulk sarcoma tumor. These cells express the marker genes of pluripotent embryonic stem cells, Stat 3, Oct 3/4, and Nanog. A subset of these cells show the surface marker of mesenchymal stem cells Stro-1, as well as express attributes of mesodermal, ectodermal, and endodermal differentiation. The isolation, purification and characterization of these stem cells now provides the ideal target for the development of highly effective therapies against tumors.

Abstract: The present invention provides a cell adhesion molecule (CAM), designated F11 receptor (F11R) and its use to inhibit platelet aggregation and platelet adhesion for the treatment and prevention of cardiovascular disorders. Cloned F11R cDNA and full length F11R cDNA and amino acid sequences are provided. F11R-antagonists and methods for the prevention and treatment of thrombosis, atherosclerosis, heart attacks, stroke and other clinical disorders involving thrombus formation are also provided. There are at least two kinds of antagonists that may be employed together. Peptides derived from the extracellular domain of F11R and small molecules and peptidomimetics based on the structure of these peptides, as well as inhibitory antibodies and functional fragments thereof, are shown to inhibit human platelet aggregation and platelet adhesion to endothelial cells, and therefore, inhibit the formation of atherosclerotic plaques.

Abstract: The present invention provides methods for predicting tolerance associated with 6-mercaptopurine drug treatment of an immune-mediated gastrointestinal disorder such as inflammatory bowel disease. In particular, the present invention provides methods for predicting a patient's risk of an adverse drug reaction (or tolerance) to a 6-mercaptopurine drug by genotyping a patient at a polymorphic site in at least one gene selected from the group consisting of a xanthine dehydrogenase (XDH) gene, molybdenum cofactor sulfurase (MOCOS) gene, and aldehyde oxidase (AOX) gene. The present invention further provides methods for optimizing therapeutic efficacy in a patient receiving a 6-mercaptopurine drug by determining whether the patient should be given an alternative drug based on the presence or absence of a polymorphism in at least one of the XDH, MOCOS, and AOX genes.

Abstract: Cloning, expression, viral and delivery vectors and hosts which contain nucleic acid coding for at least one peripheral nervous system specific (PNS) sodium channel peptide (SCP), isolated PNS SCP, and compounds and compositions and methods, are provided, for isolating, crystallizing, x-ray analysing molecular modeling, rational drug designing, selecting, making and using therapeutic or diagnostic agents or ligands having at least one peripheral nervous system specific (PNS) sodium channel (SC) modulating activity.

Abstract: A composition comprising a human- or animal-derived extracellular matrix and a macromolecular network which is prepared ex vivo is provided that is useful in the repair of a tissue injury, particularly in repair of tears or gaps between a tendon and a bone, such as in a rotator cuff tear. In an embodiment, the composition comprises a human- or animal-derived extracellular matrix having impregnated therein a macromolecular network of hyaluronan macromolecules that have been cross-linked via dihydroxyphenyl linkages, so that the cross-linked network is interlocked within the extracellular matrix. The resulting HA-incorporated extracellular matrix can be supplied in the form of a patch to reinforce a tissue repair or cover a tissue defect.

Abstract: An apparatus and method for incorporating a composition into a substrate using neutral beams are provided to repeatedly process an oxide layer using the neutral beams having low energy to minimize electrical damage to the oxide layer and improve characteristics of the oxide layer. The apparatus is mounted in a plasma generating chamber, and includes: an ion beam generating gas inlet, which injects a gas for generating ion beams; an ion source, which generates the ion beams having a polarity from the gas introduced through the ion beam generating gas inlet; a grid assembly, which is installed on one end of the ion source; a reflector, which is aligned with the grid assembly and converts the ion beams to the neutral beams; and a stage, on which the substrate is placed on a traveling path of the neutral beams. Formation of the oxide layer and application of the neutral beams are repeatedly performed on the substrate so as to improve the characteristics of the oxide layer.

Abstract: A computerized annotation method achieves real-time operation and better optimization properties while preserving the architectural advantages of the generative modeling approach. A novel clustering algorithm for objects is represented by discrete distributions, or bags of weighted vectors, thereby minimizing the total within cluster distance, a criterion used by the k-means algorithm. A new mixture modeling method, the hypothetical local mapping (HLM) method, is used to efficiently build a probability measure on the space of discrete distributions. Thus, in accord with the invention every image is characterized by a statistical distribution. The profiling model specifies a probability law for distributions directly.

Abstract: Compositions and methods for reducing the level of nornicotine and N?-nitrosonornicotine (NNN) in Nicotiana plants and plant parts thereof are provided. The compositions comprise isolated polynucleotides and polypeptides for cytochrome P450s that are involved in the metabolic conversion of nicotine to nornicotine in these plants. Expression cassettes, vectors, plants, and plant parts thereof comprising inhibitory sequences that target expression or function of the disclosed cytochrome P450 polypeptides are also provided. Methods for the use of these novel sequences to inhibit expression or function of cytochrome P450 polypeptides involved in this metabolic conversion are also provided. The methods find use in the production of tobacco products that have reduced levels of nornicotine and its carcinogenic metabolite, NNN, and thus reduced carcinogenic potential for individuals consuming these tobacco products or exposed to secondary smoke derived from these products.

Abstract: A device for replenishing ionizable material in a field ionization apparatus is disclosed. The device comprises a heatable reservoir containing the ionizable material, a field ionization electrode structure, and a channel being in fluid communication with said heatable reservoir. The heatable reservoir and the channel are designed and constructed such that when the heatable reservoir is heated to an evaporation temperature of the ionizable material, a flux of vaporized ionizable material is directed along the channel to a tip of the field ionization electrode structure.

Abstract: A signal processing device is provided, the device having a signal input for receiving a signal conveyed over a channel and defining a received signal. The device further includes one or more filters for generating a signal response based upon the received signal. The signal response includes an estimated value of a correntropy statistic. Additionally, the device includes a decision module connected to at least one of the filters for probabilistically deciding whether the received signal contains an information signal component based upon the estimated value of the correntropy statistic. The device further includes a signal output to convey a signal output indicating the received signal corresponds to a known signal template if the decision module decides that the received signal contains the information signal component.

Abstract: A carbonaceous material that has been loaded with at least one ionic organic species or hydroxide species and at least one metal or alkaline earth metal. The ionic organic species or hydroxide species is at least one selected from the group consisting of: fatty acids, surfactants, organic carboxyl species, organic sulfonate species, organic hydroxyl species, organic phenolic species, organic lactone species, organic amine species, or hydroxide species.

Abstract: A system for providing cardiac support to a patient and for promoting myocardial repair and recovery, comprises a device for connecting to a vasculature of the patient and a control module. The device includes a pump, defining a blood-receiving volume, and a cannula, in fluid communication with the blood-receiving volume, for anatomizing to the vasculature of the patient such that the blood-receiving volume may receive blood from and return blood to the vasculature of the patient through the cannula. The control module is for controlling the device and includes a means for establishing user-defined parameters, and a means for operating the pump of the device, which is in communication with the means for establishing user-defined parameters such that the operation of the pump is in response to the established user-defined parameters.

Abstract: A method of designing a transmissive optical element for converting a profile of a light beam from a predetermined input profile to a predetermined output profile is disclosed. The method comprises: calculating a stationary function of a predetermined cost functional selected such that the stationary function satisfies a mapping condition for mapping the predetermined input profile into the predetermined output profile, thereby providing a mapping function. The method further comprises utilizing the mapping function for calculating surface properties of at least a first surface and a second surface of the transmissive optical element.

Abstract: The invention provides an isolated H3 equine influenza A virus, as well as methods of preparing and using the virus, and genes or proteins thereof.

Abstract: Disclosed are methods, compositions, and kits for inducing polyclonal antibodies against one or more pathogens that include Streptococcus suis. The methods may include administering to an animal a composition that includes an isolated 38 kDa polypeptide of Streptococcus suis and a suitable excipient. The methods, compositions, and kits may be used to immunize an animal against infection by Streptococcus suis.

Abstract: According to various aspects, exemplary embodiments are provided of thermopneumatic capillary micropumps and manufacturing methods thereof. In one exemplary embodiment, a thermopneumatic capillary micropump generally includes a lower substrate having a pump-entrance for injecting fluids and a pump-exit for exhausting the fluids. The micropump also includes one or more micro-heaters for generating heat and electrodes for applying voltage to the micro-heaters. One or more air chambers substantially cover the micro-heaters. A pump chamber unit, which is capable of being filled up with the fluids, is coupled to the air chambers, the pump-entrance, and the pump-exit. An airing channel is coupled to the air chambers for helping maintain the pressure of the air in the air chambers at about the same level. An oxide layer is deposited on an upper substrate of the micropump. The upper and lower substrates are thermopneumatically coupled to each other.